PC
PRXL

PointState Capital’s Parexel International Corp PRXL Stock Holding History

PointState Capital’s Portfolio PRXL Stock Details PRXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-12,500
Closed -$1.09M – 186
2017
Q2 		$1.09M Buy
+12,500
New +$932K 0.01% 124

Other funds holding PRXL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GLAM
Gardner Lewis Asset Management Chadds Ford, Pennsylvania $462M AUM 65.29% 1-Year Est. Return
WIC
Water Island Capital New York $896M AUM 107.59% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

PointState Capital's PRXL Position: Q3 2017 in Review

PointState Capital sold out of Parexel International Corp (PRXL) in Q3 2017, closing a stake of 12,500 shares — an estimated $1.09M sold.

PointState Capital first reported a position in PRXL in Q2 2017 and held it in 1 quarter. The position peaked at $1.09M in Q2 2017. 246 funds tracked by Wall St. Rank hold PRXL as of Q3 2017.

  • PointState Capital reported no remaining Parexel International Corp position as of Q3 2017 after selling out during the quarter.
  • PointState Capital sold 12,500 Parexel International Corp shares in Q3 2017, an estimated $1.09M.
  • PointState Capital first reported a position in Parexel International Corp in Q2 2017 and held it in 1 quarter.
  • PointState Capital's Parexel International Corp position peaked at $1.09M in Q2 2017.
  • 246 funds tracked by Wall St. Rank held Parexel International Corp as of Q3 2017.

Based on PointState Capital's 13F filing for Q3 2017, filed 14 Nov 2017.